EUVIMEDEUVIMED entdecken
Open Access

A BMP-2–triggered in vivo osteo-organoid for cell therapy

Kai Dai iD, Qinghao Zhang iD, Shunshu Deng, Yuanman Yu iD, Fuwei Zhu, Shuang Zhang, YuanZhong Pan iD, Dandan Long, Jing Wang iD, Changsheng Liu iD

Science Advances · 06.01.2023 · 9 (1)

DOI: 10.1126/sciadv.add1541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 06.01.2023. Verfasst von Kai Dai und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Liver. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell therapies and regenerative medicine interventions require an adequate source of therapeutic cells. Here, we demonstrate that constructing in vivo osteo-organoids by implanting bone morphogenetic protein–2–loaded scaffolds into the internal muscle pocket near the femur of mice supports the growth and subsequent harvest of therapeutically useful cells including hematopoietic stem/progenitor cells (HSPCs), mesenchymal stem cells (MSCs), lymphocytes, and myeloid cells. Profiling of the in vivo osteo-organoid maturation process delineated three stages—fibroproliferation, osteochondral differentiation, and marrow generation—each of which entailed obvious changes in the organoid structure and cell type distribution. The MSCs harvested from the osteochondral differentiation stage mitigated carbon tetrachloride (CCl 4 )–induced chronic liver fibrosis in mice, while HSPCs and immune cells harvested during the marrow generation stage rapidly and effectively reconstituted the impaired peripheral and solid immune organs of irradiated mice. These findings demonstrate the therapeutic potentials of in vivo osteo-organoid–derived cells in cell therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem CellsLiverAnimalsMiceCell DifferentiationCell- and Tissue-Based TherapyOrganoidsBone Morphogenetic Protein 2

Substanzen

Bmp2 protein, mouseBone Morphogenetic Protein 2

Autor:innen und Institutionen

  • State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China.
  • Engineering Research Center for Biomedical Materials of the Ministry of Education, East China University of Science and Technology, Shanghai 200237, PR China.
  • Frontiers Science Center for Materiobiology and Dynamic Chemistry, East China University of Science and Technology, Shanghai 200237, PR China.
  • Key Laboratory for Ultrafine Materials of the Ministry of Education, East China University of Science and Technology, Shanghai 200237, PR China.

ORCID-Profile: Kai Dai, Qinghao Zhang, Yuanman Yu, YuanZhong Pan, Jing Wang, Changsheng Liu

Zitieren

APA

Dai, K., Zhang, Q., Deng, S., Yu, Y., Zhu, F., Zhang, S., Pan, Y., Long, D., Wang, J., & Liu, C. (2023). A BMP-2–triggered in vivo osteo-organoid for cell therapy. Science Advances, 9(1). https://doi.org/10.1126/sciadv.add1541

Vancouver

Dai K, Zhang Q, Deng S, Yu Y, Zhu F, Zhang S, et al. A BMP-2–triggered in vivo osteo-organoid for cell therapy. Science Advances. 2023;9(1). doi:10.1126/sciadv.add1541

BibTeX
@article{Dai2023,
  author = {Dai, Kai and Zhang, Qinghao and Deng, Shunshu and Yu, Yuanman and Zhu, Fuwei and Zhang, Shuang and Pan, YuanZhong and Long, Dandan and Wang, Jing and Liu, Changsheng},
  title = {A BMP-2–triggered in vivo osteo-organoid for cell therapy},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {1},
  doi = {10.1126/sciadv.add1541}
}
Kostenlos starten →